Welcome to our dedicated page for HEALTHSTREAM SEC filings (Ticker: HSTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HEALTHSTREAM's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HEALTHSTREAM's regulatory disclosures and financial reporting.
GORDON FRANK reported acquisition or exercise transactions in this Form 4 filing.
HealthStream director Frank Gordon reported new equity compensation awards rather than open-market trades. On May 28, 2026, he received 1,482 shares of common stock at $24.63 per share, which he elected to take in stock instead of cash for his Board service. Following this award, his direct common stock holdings total 212,404 shares.
He was also granted 3,654 restricted share units (RSUs), each representing the right to receive one share of common stock upon vesting. These RSUs vest over a three-year schedule, in three equal annual installments beginning on May 28, 2027, contingent on continued service. The filing also lists several indirect ownership accounts, including family trusts, custodial accounts for minor children, and entities such as The Joel Company and Crofton Capital.
HealthStream Inc. director Linda Rebrovick reported an open-market sale of 2,000 shares of common stock at $25.00 per share on May 28, 2026. The transaction was executed under a pre-arranged Rule 10b5-1 sales plan adopted on November 21, 2025. After this sale, she directly holds 56,181 HealthStream shares.
HealthStream, Inc. reported the final voting results from its May 28, 2026 annual meeting of shareholders. Director nominees received the following votes: A. Alex Jahangir had 22,452,989 votes for, 2,421,416 withheld, and 2,654,245 broker non-votes; Jeffrey L. McLaren had 14,484,114 for, 10,390,291 withheld, and 2,654,245 broker non-votes; and Linda Rebrovick had 23,316,490 for, 1,557,915 withheld, and 2,654,245 broker non-votes.
Shareholders also voted on two additional proposals. One proposal received 27,171,627 votes for, 355,926 against, and 1,097 abstentions with no broker non-votes. Another proposal received 23,852,346 votes for, 1,019,058 against, 3,001 abstentions, and 2,654,245 broker non-votes. Directors not up for election continue to serve on the Board.
HSTM filed a Form 144 notice reporting proposed sales of Common Stock through J.P. Morgan Securities LLC. The filing lists a proposed quantity of 3,000 shares associated with the broker and records two RSU awards dated 02/26/2025 (1,945 shares) and 03/26/2025 (1,055 shares). The filing shows a date of 05/20/2026.
HealthStream’s Executive Vice President Kevin P. O’Hara reported an open-market sale of 3,000 shares of the company’s common stock. The shares were sold at a weighted average price of $24.0765 per share, in multiple trades executed between $24.01 and $24.10.
After this transaction, O’Hara directly holds 20,982 shares of HealthStream common stock. The filing notes that detailed trade-by-trade pricing and share information is available on request for regulators, the company, or its shareholders.
HealthStream Inc executive Michael Manning Collier reported a new stock option award. He received 18,781 employee stock options to buy HealthStream common stock at an exercise price of $23.96 per share, expiring on May 8, 2036. These options vest over four years, with 15% vesting on May 8, 2027, 20% on each of May 8, 2028, May 8, 2029, and May 8, 2030, and the remaining 25% on May 8, 2031, contingent on continued service. Following this filing, he directly holds 60,293 shares of HealthStream common stock.
HEALTHSTREAM INC CEO and Chairman Robert A. Frist Jr. reported an equity compensation grant and updated indirect and direct holdings in HealthStream common stock. The filing shows a grant of employee stock options covering 18,781 shares of common stock at an exercise price of $23.96 per share.
The options vest over four years, with 15% on May 8, 2027, 20% on each of May 8, 2028, 2029, and 2030, and the remaining 25% on May 8, 2031, contingent on continued service. After this grant, Frist holds 4,051,106 shares directly, plus several indirect positions through various family and children’s trusts, including 995,000 shares held by the Bobby and Melissa Frist Children’s 2012 GST-Exempt Trust.
HealthStream, Inc. has promoted Michael M. Collier to Chief Operating Officer and Executive Vice President from his prior corporate strategy and operations role. He will oversee enterprise operations, including customer experience, corporate development, M&A, implementations, legal, HR, partnerships, business enablement, and other key functions.
Collier will also act as executive sponsor for the company’s AI transformation. In connection with his promotion, he received stock options for 18,781 shares at an exercise price of $23.96 per share under the 2022 Omnibus Incentive Plan, vesting over five years, and an increased base salary with eligibility for executive-level bonuses and time-based RSU awards.
The Compensation Committee also granted the CEO, Robert A. Frist, Jr., stock options for 18,781 shares at the same $23.96 exercise price, with identical five-year time-based vesting tied to continued service.
HealthStream, Inc. reported solid growth for the quarter ended March 31, 2026. Revenues rose to $81.2 million, up 11% from $73.5 million a year earlier, driven mainly by subscription services of $78.4 million and modest growth in professional services.
Operating income increased to $7.5 million from $4.4 million, while net income improved to $5.9 million, or $0.20 diluted EPS, compared with $4.3 million, or $0.14 diluted EPS, in the prior-year quarter. Adjusted EBITDA reached $20.1 million, up from $16.2 million.
The company ended the quarter with $48.7 million in cash and cash equivalents and $17.8 million in marketable securities, and had no outstanding borrowings under its $50 million revolving credit facility. It returned capital through $7.7 million of share repurchases and a quarterly dividend of $0.035 per share.